Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (151-160 of 335) with videos related to

Pageof 34
Sort By:
The Journal of Biological Chemistry|March 10, 2017
Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiationShinji Go, Shiori Go, Lucas Veillon, et al.
International Journal of Molecular Sciences|March 29, 2023
Combined Inhibition of Hedgehog and HDAC6: In Vitro and In Vivo Studies Reveal a New Role for Lysosomal Stress in Reducing Glioblastoma Cell ViabilityAlex Pezzotta, Loredana Brioschi, Sabrina Carbone, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 17, 2007
Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS studyBarry T Katzen, Frank J Criado, Stephen R Ramee, et al.
The American Journal of Cardiology|August 30, 2016
Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting StentMonique Ten Haaf, Yolande Appelman, William Wijns, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)Eric L Eisenstein, Martin B Leon, David E Kandzari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2013
Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologiesMoshe Vardi, Victor Novack, Michael J Pencina, et al.
American Heart Journal|August 16, 2019
The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationaleLaura Mauri, Gheorghe Doros, Sunil V Rao, et al.
JACC. Cardiovascular Interventions|May 6, 2017
Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy StudyEric A Secemsky, Robert W Yeh, Dean J Kereiakes, et al.
The New England Journal of Medicine|September 26, 2008
Drug-eluting or bare-metal stents for acute myocardial infarctionLaura Mauri, Treacy S Silbaugh, Pallav Garg, et al.
Science Signaling|October 13, 2016
Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophilsHitoshi Nakayama, Hidetake Kurihara, Yasu S Morita, et al.
Pageof 34

Showing results (151-160 of 335) with videos related to

Sort By:
Pageof 34
The Journal of Biological Chemistry|March 10, 2017
Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiationShinji Go, Shiori Go, Lucas Veillon, et al.
International Journal of Molecular Sciences|March 29, 2023
Combined Inhibition of Hedgehog and HDAC6: In Vitro and In Vivo Studies Reveal a New Role for Lysosomal Stress in Reducing Glioblastoma Cell ViabilityAlex Pezzotta, Loredana Brioschi, Sabrina Carbone, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 17, 2007
Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS studyBarry T Katzen, Frank J Criado, Stephen R Ramee, et al.
The American Journal of Cardiology|August 30, 2016
Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting StentMonique Ten Haaf, Yolande Appelman, William Wijns, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)Eric L Eisenstein, Martin B Leon, David E Kandzari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2013
Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologiesMoshe Vardi, Victor Novack, Michael J Pencina, et al.
American Heart Journal|August 16, 2019
The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationaleLaura Mauri, Gheorghe Doros, Sunil V Rao, et al.
JACC. Cardiovascular Interventions|May 6, 2017
Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy StudyEric A Secemsky, Robert W Yeh, Dean J Kereiakes, et al.
The New England Journal of Medicine|September 26, 2008
Drug-eluting or bare-metal stents for acute myocardial infarctionLaura Mauri, Treacy S Silbaugh, Pallav Garg, et al.
Science Signaling|October 13, 2016
Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophilsHitoshi Nakayama, Hidetake Kurihara, Yasu S Morita, et al.
Pageof 34